A study reported a trispecific NKCE platform, including α-CD16, α-4-1BB, α-EGFR and epirubicin (EPI), which facilitated the recruitment and activation of NK cells, which can ultimately promote NK cell recruitment and activation to eradicate these cancer cells 133. This evidence concerns the gene EGFR and cancer.